Sabby Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-161,670
| Closed | -$669K | – | 202 |
|
|
2017
Q1 | $669K | Buy |
+161,670
| New | +$669K | 0.04% | 67 |
|
|
2016
Q4 | – | Sell |
-39,817
| Closed | -$392K | – | 237 |
|
|
2016
Q3 | $392K | Sell |
39,817
-104,250
| -72% | -$1.03M | 0.01% | 106 |
|
|
2016
Q2 | $815K | Buy |
144,067
+20,900
| +17% | +$118K | 0.04% | 84 |
|
|
2016
Q1 | $939K | Buy |
+123,167
| New | +$939K | 0.05% | 87 |
|
|
2015
Q2 | – | Sell |
-69,659
| Closed | -$681K | – | 233 |
|
|
2015
Q1 | $681K | Sell |
69,659
-51,091
| -42% | -$499K | 0.03% | 89 |
|
|
2014
Q4 | $1.38K | Sell |
120,750
-68,599
| -36% | -$782 | 0.04% | 60 |
|
|
2014
Q3 | $2.18K | Buy |
+189,349
| New | +$2.18K | 0.08% | 32 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 164 |
|
|
2014
Q1 | – | Sell |
-119,667
| Closed | -$1.26M | – | 157 |
|
|
2013
Q4 | $1.26M | Buy |
119,667
+9,734
| +9% | +$103K | 0.08% | 34 |
|
|
2013
Q3 | $1.36M | Buy |
+109,933
| New | +$1.36M | 0.09% | 29 |
|